AnalystsTrung Huynh
Trung Huynh's Stock Forecasts

Analyst Ranking
Top 8%
#418 out of 5223 analysts
Average Return
+23.57%
Win Rate
64%27 out of 42
Risk vs Reward
Poor
Good

Trung Huynh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+167.19%$29.23$78.10
2024-02-26 -
2025-02-26
Strong Buy
Cabaletta Bio IncCABA
+151.28%$1.17$2.94
2025-03-31 -
2026-03-20
Strong Buy
Insmed IncINSM
+108.97%$65.08$136.00
2025-05-09 -
2026-03-20
Strong Buy
Insmed IncINSM
+91.38%$75.02$143.57
2025-03-06 -
2026-03-05
Strong Buy
Eli Lilly & CoLLY
+85.30%$395.86$733.51
2023-04-27 -
2024-04-26
Buy

Trung Huynh Analyst Color

Get additional color on Trung Huynh's coverage of popular stocks

Trung Huynh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pfizer IncPFE
7Sell$25.00-7.30%Initiates Coverage On
24 days ago
Eli Lilly & CoLLY
11Buy$1,250.00+37.86%Initiates Coverage On
24 days ago
Bristol Myers Squibb CoBMY
6Hold$60.00+4.38%Initiates Coverage On
24 days ago
Abbvie IncABBV
2Buy$260.00+26.79%Initiates Coverage On
24 days ago
Merck & Co IncMRK
5Buy$142.00+24.37%Initiates Coverage On
24 days ago
Regeneron Pharmaceuticals IncREGN
5Hold$660.00-9.94%Maintains
4 months ago
Insmed IncINSM
9Strong Buy$223.00+63.97%Maintains
5 months ago
Jasper Therapeutics IncJSPR
3Strong Buy$25.00+1,932.52%Maintains
7 months ago
Amgen IncAMGN
6Hold$317.00-8.86%Maintains
7 months ago
Celldex Therapeutics IncCLDX
2Strong Buy$38.00+22.98%Maintains
10 months ago
Cabaletta Bio IncCABA
2Strong Buy$7.00+138.10%Maintains
a year ago
Kyverna Therapeutics IncKYTX
1Strong Buy$13.00N/AInitiates Coverage On
a year ago
Johnson & JohnsonJNJ
2Hold$175.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.